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perform the validation (Table 1). Our validation resulted in 
an AUC of 0.62. The AUC increased to 0.76 after we removed 
all duplicate patients due to multiple false-positive tumor 
length 'hits' per patient during automated free text 
search.
 
 
Conclusions: We describe a method to extract data from 
multiple sources, and to apply a prediction model on routine 
clinical patient data. Although the free text extraction was 
not perfect and the number of patients in our validation was 
low (N=38), we have successfully shown a method for 
automatically (nightly) applying prediction models in clinical 
practice, and thus enabling use of prediction results for 
treatment decisions. Unfortunately, there is still a need to 
enhance data collection at the source. For example, the 
availability of pCR was our most limiting factor (only 4% of 
patients). Furthermore, the extraction of tumor length from 
free text reports remains necessary until available in a 
structured format. 
Based on this method, future work consists of adding more 
data sources and routine clinical validation of prediction 
models.  
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Purpose/Objective: A re-organisation of surgery of rectal 
cancer among reference hospitals was implemented in 2011 
based on the results of a clinical audit. The aim of this study 
was to assess the impact of centralization of rectal cancer 
surgery on radiotherapy patterns of care and its impact on 
clinical outcomes. 
Materials and Methods: Quality of rectal cancer care was 
assessed by means of a clinical audit (retrospective cohort 
study) of all patients receiving treatment for rectal cancer 
with a radical intent in public hospitals in Catalonia in two-
time periods (2005/7 and 2011/12). Radiotherapy patterns of 
care as well as clinical outcomes, comparing both periods, 
were analysed in order to measure the impact of 
centralization. Clinical practice was compared with evidence-
based clinical guidelines.  
Results: From 2005/7 to 2011/12 the number of hospitals 
performing rectal cancer surgery decreased from 51 to 29. 
The study covered 2553 patients with TNM stage-II or III 
primary rectal cancer. From 2005/7 to 2011/12 the number 
of patients receiving radiotherapy for their rectal cancer, 
either pre o postoperatively, has increased from 72.2 to 
76.2% (p=0.025). Delivering pre-operative radiotherapy ± 
chemotherapy (RT/ChT) increased from 57.3 to 66.2% 
(p<0.001). Short course radiotherapy increased from 2% to 
7%. 
When comparing patient characteristics broken down by 
neo(adjuvant) treatment, patients with pre-operative 
RT/ChT are marked by: a younger age; a lower surgical risk 
and a tumour site more frequently located in the distal 
rectum, and this in both periods. 
The crude local recurrence rate at 1 year of follow-up was 
3.1%.  
The results of the univariate COX regression analyse showed a 
local-recurrence rate hazard ratio of 1.9 for the group of 
patients that did not receive any radiotherapy versus the 
group that received preoperative radiotherapy (p=0.019). In 
the multivariate COX regression analysis, TNM stage, type of 
neo(adjuvant) treatment and type of surgical intervention 
were independent predictors of risk of local recurrence at 1 
year of follow-up. 
Further follow-up is ongoing. 
Conclusions: Centralising surgery into high volume providers 
could be associated with improved adherence to radiotherapy 
recommendations, possibly as a result of more structured 
multidisciplinary decisions.  
Health policy approach combining assessment from the 
clinical audit with reorganisation of the delivery of complex 
treatments has been associated with better outcomes. A 
model of care based on the centralisation of high-complexity 
cancer treatments should be supported by managed regional 
networks and improved referral of patients.  
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Purpose/Objective: Intensity modulated radiotherapy 
(IMRT), including volumetric arc therapy (VMAT) and helical 
IMRT (HT) techniques, has been only recently introduced in 
the treatment of anal canal cancer patients. We 
retrospectively assessed efficacy and safety of IMRT, VMAT, 
HT and daily image-guided RT (IGRT) for anal canal cancer. 
Materials and Methods: Data of patients with a diagnosis of 
anal canal squamous-cell carcinoma treated with curative 
intent in two academic radiation oncology departments were 
analyzed. Local control (LC) and grade 3 or more toxicity rate 
(CTC-AE v.4.0) were the primary endpoints. Overall (OS), 
disease-free (DFS), and colostomy-free survival (CFS) are also 
reported. Anal canal, mesorectal, pelvic, and inguinal nodes 
received a total dose of 36 Gy (1.8 Gy/fr) using IMRT or VMAT 
or HT (depending on the treating center). A sequential boost 
to the anal canal and positive nodes (total dose: 59.4-60 
Gy,1.8-2 Gy/fr) was delivered with IMRT, VMAT, HT or 3D-
conformal RT (CRT). Planning target volume was obtained 
adding 5-mm margin to the clinical target volume. 
Results: Between 03.2006 and 05.2014, a total of 137 
patients was treated; 15, 62, 31 and 28 patients presented 
